As for the cGMP signalling pathway, reduced soluble guanylyl cyclase (sGC) activity has been observed in the superior temporal cortex of AD patient and in reactive astrocytes surrounding Aβ plaques [155,156]. Here, SGCB is linked to Alzheimer disease.